Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd (CHEMIESYNT): company summary
The company's revenue grew 13.5% annually, but net profit turned from a zero loss to a ₹1 crore loss, widening the net profit margin from -0.6% to -4.6%.
Chemiesynth (Vapi) Ltd (CHEMIESYNT) is a micro-cap Chemicals company valued at ₹37 crore operating in Specialty Chemicals on the NSE and BSE.
- Recent price move
- Chemiesynth (Vapi) Ltd last traded at ₹119.97, unchanged on the day.
- Recent developments
- 2026-09-30: Promoter holding remained at 62.35%, with no changes in foreign or domestic institutional holdings. 2026-06-30: The company reported a net loss of ₹1 crore for the latest quarter, continuing a trend of widening losses from the previous year.
- Financial performance
- The company's revenue grew 13.5% annually, but net profit turned from a zero loss to a ₹1 crore loss, widening the net profit margin from -0.6% to -4.6%. In the latest quarter, revenue rose 5.8% year-on-year, but the net loss widened from ₹0 crore to ₹1 crore, with the net profit margin dropping to -4.6%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 2.87 times book value.
- Things to watch
- The company reported a net loss of ₹1 crore in its latest financial year, with the net profit margin worsening to -4.6%. The debt to equity ratio stands at 1.59, indicating higher leverage. The latest quarter net loss widened from ₹0 crore to ₹1 crore, showing persistent pressure on profitability.
- Where it stands
- Chemiesynth (Vapi) Ltd ended its latest quarter with a net loss of ₹1 crore, continuing a trend of widening losses from the previous year. The net profit margin dropped to -4.6%, and the debt to equity ratio remains at 1.59. The stock is at its 52-week high, with no institutional holdings reported.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by momentum (7.5), but held back by growth (0.7). Momentum looks strong at 7.5, but that is offset by growth at 0.7 and quality at 1.2. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Loss-making — no meaningful P/E
- High leverage — debt is 1.6× equity
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Specialty Chemicals
Explore Chemiesynth (Vapi) Ltd’s valuation
Free deep-dive tools · no sign-up
Chemiesynth (Vapi) Ltd peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Chemiesynth (Vapi) Ltd with the ratios and calculators DocStoX uses in its analysis.

